Author:
Chambers Stephen T.,Storer Malina,Scott-Thomas Amy,Slow Sandy,Williman Jonathan,Epton Michael,Murdoch David R.,Metcalf Sarah,Carr Anitra,Isenman Heather,Maze Michael
Abstract
AbstractPatients hospitalised with community acquired pneumonia (CAP) have low peripheral blood vitamin C concentrations and limited antioxidant capacity. The feasibility of a trial of vitamin C supplementation to improve patient outcomes was assessed. Participants with moderate and severe CAP (CURB-65 ≥ 2) on intravenous antimicrobial treatment were randomised to either intravenous vitamin C (2.5 g 8 hourly) or placebo before switching to oral intervention (1 g tds) for 7 days when they were prescribed oral antimicrobial therapy. Of 344 patients screened 75 (22%) were randomised and analysed. The median age was 76 years, and 43 (57%) were male. In each group, one serious adverse event that was potentially intervention related occurred, and one subject discontinued treatment. Vitamin C concentrations were 226 µmol/L in the vitamin C group and 19 µmol/L in the placebo group (p < 0.001) after 3 intravneous doses. There were no signficant differences between the vitamin C and placebo groups for death within 28 days (0 vs. 2;p = 0.49), median length of stay (69 vs. 121 h;p = 0.07), time to clinical stability (22 vs. 49 h;p = 0.08), or readmission within 30 days (1 vs. 4;p = 0.22). The vitamin C doses given were safe, well tolerated and saturating. A randomised controlled trial to assess the efficacy of vitamin C in patients with CAP would require 932 participants (CURB-65 ≥ 2) to observe a difference in mortality and 200 participants to observe a difference with a composite endpoint such as mortality plus discharge after 7 days in hospital. These studies are feasible in a multicentre setting.
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Padhani, Z. A. et al. Vitamin C supplementation for prevention and treatment of pneumonia. Cochrane Database Syst. Rev. 4(4), Cd013134 (2020).
2. Lim, W. S. et al. Defining community acquired pneumonia severity on presentation to hospital: An international derivation and validation study. Thorax 58(5), 377–382 (2003).
3. Carr, A. C., Spencer, E., Dixon, L. & Chambers, S. T. Patients with community acquired pneumonia exhibit depleted vitamin C status and elevated oxidative stress. Nutrients 12(5), 1318 (2020).
4. Carr, A. C. et al. Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes. Crit. Care 21(1), 300 (2017).
5. Carr, A. C. & Maggini, S. Vitamin C and immune function. Nutrients 9(11), 1211 (2017).